The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...

Apollo endocrinologist explains the key difference between belly fat and visceral fat, warning that even people with normal ...

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

Introduction: Subcutaneous emphysema (SE) is a clinical condition that occurs when air gets into soft tissues under the skin. This can occur in any part of the body depending on the type of pathology.

Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.

Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...

Excess abdominal fat, particularly visceral fat, actively triggers morning blood sugar spikes by causing liver insulin ...

Subcutaneous amivantamab offers a convenient alternative to IV administration for EGFR-mutated NSCLC, reducing infusion-related reactions and administration time. The PALOMA-3 trial confirmed ...